Evidence map›Paper›PMID 37703328›Full record

ArticleBrain : a journal of neurology2024

Autosomal dominant in cis D4Z4 repeat array duplication alleles in facioscapulohumeral dystrophy.

Richard J L F Lemmers, Russell Butterfield, Patrick J van der Vliet, Jan L de Bleecker, Ludo van der Pol, Diane M Dunn, Corrie E Erasmus, Marc D'Hooghe, Kristof Verhoeven, Judit Balog and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 14 institutions in 6 countries.

Richard J L F LemmersDepartment of Human Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.ORCID 0000-0002-7102-710X
Russell ButterfieldDepartment of Pediatrics, University of Utah, Salt Lake City, UT 84112, USA.
Patrick J van der VlietDepartment of Human Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
Jan L de BleeckerDepartment of Neurology, University Hospital, 9000 Gent, Belgium.
Ludo van der PolUniversity Medical Center Utrecht, 3584 EA, Utrecht, The Netherlands.
Diane M DunnDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.
Corrie E ErasmusNeuromuscular Centre Nijmegen, Radboud University Nijmegen Medical Centre, 6525 GA, Nijmegen, The Netherlands.
Marc D'HoogheDepartment of Neurology, Algemeen Ziekenhuis Sint-Jan, 8000, Brugge, Belgium.
Kristof VerhoevenDepartment of Neurology, Algemeen Ziekenhuis Sint-Jan, 8000, Brugge, Belgium.
Judit BalogDepartment of Human Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
Anne BigotSorbonne Université, Inserm UMRS974, Institut de Myologie, Centre de Recherche en Myologie, F-75013 Paris, France.
Baziel van EngelenNeuromuscular Centre Nijmegen, Radboud University Nijmegen Medical Centre, 6525 GA, Nijmegen, The Netherlands.
Jeffrey StatlandUniversity of Kansas Medical Center, Kansas City, KS 66103, USA.
Enrico BugiardiniNational Hospital For Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.ORCID 0000-0002-9709-6699
Nienke van der StoepDepartment of Clinical Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.
Teresinha EvangelistaUnité de Morphologie Neuromusculaire, Institut de Myologie, AP-HP, F-75013, Paris, France.
Chiara Marini-BettoloThe John Walton Muscular Dystrophy Research Centre, Faculty of Medical Sciences, Newcastle upon Tyne, NE1 3BZ, UK.
Peter van den BerghDepartment of Neurology, Saint-Luc UCL, 1200, Brussels, Belgium.
Rabi TawilDepartment of Neurology, University of Rochester Medical Center, NY 14642, Rochester, USA.
Nicol C VoermansNeuromuscular Centre Nijmegen, Radboud University Nijmegen Medical Centre, 6525 GA, Nijmegen, The Netherlands.
John VissingDepartment of Neurology, University of Copenhagen, DK-2100 Copenhagen, Denmark.
Robert B WeissDepartment of Human Genetics, University of Utah, Salt Lake City, UT 84112, USA.
Silvère M van der MaarelDepartment of Human Genetics, Leiden University Medical Center, 2300 RC, Leiden, The Netherlands.ORCID 0000-0001-8103-711X
Leiden University Medical Center · NLRadboud University Nijmegen · NLUniversity of Utah · USAZ Sint-Jan · BEAssistance Publique – Hôpitaux de Paris · FRCliniques Universitaires Saint-Luc · BEGhent University Hospital · BEInserm · FRMuscular Dystrophy UK · GBNational Hospital for Neurology and Neurosurgery · GBUniversity of Copenhagen · DKUniversity of Kansas Medical Center · USUniversity of Rochester Medical Center · USUtrecht University · NL

Funding

Training Core [Parent Title: NOVEL THERAPEUTICS FOR FSHD]P50HD060848 · NICHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI EMERSON, CHARLES P. · 2018 to 2023
$8.6M
SMCHD1 Pathways as Candidate Targets for FSHDR01AR066248 · NIAMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TAPSCOTT, STEPHEN J · 2014 to 2024
$4.5M
NIAMS NIH HHS R01 AR066248NICHD NIH HHS P50 HD060848NIH HHS P50 HD060848
6 · The paper itself

Abstract

Facioscapulohumeral dystrophy (FSHD) has a unique genetic aetiology resulting in partial chromatin relaxation of the D4Z4 macrosatellite repeat array on 4qter. This D4Z4 chromatin relaxation facilitates inappropriate expression of the transcription factor DUX4 in skeletal muscle. DUX4 is encoded by a retrogene that is embedded within the distal region of the D4Z4 repeat array. In the European population, the D4Z4 repeat array is usually organized in a single array that ranges between 8 and 100 units. D4Z4 chromatin relaxation and DUX4 derepression in FSHD is most often caused by repeat array contraction to 1-10 units (FSHD1) or by a digenic mechanism requiring pathogenic variants in a D4Z4 chromatin repressor like SMCHD1, combined with a repeat array between 8 and 20 units (FSHD2). With a prevalence of 1.5% in the European population, in cis duplications of the D4Z4 repeat array, where two adjacent D4Z4 arrays are interrupted by a spacer sequence, are relatively common but their relationship to FSHD is not well understood. In cis duplication alleles were shown to be pathogenic in FSHD2 patients; however, there is inconsistent evidence for the necessity of an SMCHD1 mutation for disease development. To explore the pathogenic nature of these alleles we compared in cis duplication alleles in FSHD patients with or without pathogenic SMCHD1 variant. For both groups we showed duplication-allele-specific DUX4 expression. We studied these alleles in detail using pulsed-field gel electrophoresis-based Southern blotting and molecular combing, emphasizing the challenges in the characterization of these rearrangements. Nanopore sequencing was instrumental to study the composition and methylation of the duplicated D4Z4 repeat arrays and to identify the breakpoints and the spacer sequence between the arrays. By comparing the composition of the D4Z4 repeat array of in cis duplication alleles in both groups, we found that specific combinations of proximal and distal repeat array sizes determine their pathogenicity. Supported by our algorithm to predict pathogenicity, diagnostic laboratories should now be furnished to accurately interpret these in cis D4Z4 repeat array duplications, alleles that can easily be missed in routine settings.

Indexed as

Muscular Dystrophy, FacioscapulohumeralAllelesChromatinChromosomal Proteins, Non-HistoneHomeodomain ProteinsHumansChromatinChromosomal Proteins, Non-HistoneHomeodomain ProteinsSMCHD1 protein, humanD4Z4duplicationsDUX4facioscapulohumeral muscular dystrophyFSHD

Identifiers

PMID37703328
PMCPMC10834250
OpenAlexW4386694118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.